 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 13, 981-989, Copyright © 1993 by Society for Neuroscience
Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
J Urenjak, SR Williams, DG Gadian and M Noble
Department of Biophysics, Hunterian Institute, Royal College of Surgeons of England, London.
Proton nuclear magnetic resonance (1H NMR) spectroscopy is a noninvasive
technique that can provide information on a wide range of metabolites.
Marked abnormalities of 1H NMR brain spectra have been reported in patients
with neurological disorders, but their neurochemical implications may be
difficult to appreciate because NMR data are obtained from heterogeneous
tissue regions composed of several cell populations. The purpose of this
study was to examine the 1H NMR profile of major neural cell types. This
information may be helpful in understanding the metabolic abnormalities
detected by 1H NMR spectroscopy. Extracts of cultured cerebellar granule
neurons, cortical astrocytes, oligodendrocyte-type 2 astrocyte (O-2A)
progenitor cells, oligodendrocytes, and meningeal cells were analyzed. The
purity of the cultured cells was > 95% with all the cell lineages,
except for neurons (approximately 90%). Although several constituents
(creatine, choline- containing compounds, lactate, acetate, succinate,
alanine, glutamate) were ubiquitously detectable with 1H NMR, each cell
type had distinctive qualitative and/or quantitative features. Our most
unexpected finding was a large amount of N-acetyl-aspartate (NAA) in O- 2A
progenitors. This compound, consistently detected by 1H NMR in vivo, was
previously thought to ne present only in neurons. The finding that
meningeal cells have an alanine:creatine ratio three to four times higher
than astrocytes, neurons, or oligodendrocytes is in agreement with
observations that meningiomas express a higher alanine:creatine ratio than
gliomas. The data suggest that each individual cell type has a
characteristic metabolic pattern that can be discriminated by 1H NMR, even
by looking at only a few metabolites (e.g., NAA, glycine, beta-
hydroxybutyrate).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
S. D. Friedman
Comment on "Magnetic Resonance Spectroscopy Identifies Neural Progenitor Cells in the Live Human Brain"
Science,
August 1, 2008;
321(5889):
640c - 640c.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gabis, Wei Huang, A. Azizian, C. DeVincent, A. Tudorica, Y. Kesner-Baruch, P. Roche, and J. Pomeroy
1H-Magnetic Resonance Spectroscopy Markers of Cognitive and Language Ability in Clinical Subtypes of Autism Spectrum Disorders
J Child Neurol,
July 1, 2008;
23(7):
766 - 774.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kantarci, D. S. Knopman, D. W. Dickson, J. E. Parisi, J. L. Whitwell, S. D. Weigand, K. A. Josephs, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr
Alzheimer Disease: Postmortem Neuropathologic Correlates of Antemortem 1H MR Spectroscopy Metabolite Measurements
Radiology,
July 1, 2008;
248(1):
210 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Gabbay, D. A. Hess, S. Liu, J. S. Babb, R. G. Klein, and O. Gonen
Lateralized Caudate Metabolic Abnormalities in Adolescent Major Depressive Disorder: A Proton MR Spectroscopy Study
Am J Psychiatry,
December 1, 2007;
164(12):
1881 - 1889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. De Stefano, M. Filippi, D. Miller, P. J. Pouwels, A. Rovira, A. Gass, C. Enzinger, P. M. Matthews, and D. L. Arnold
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies
Neurology,
November 13, 2007;
69(20):
1942 - 1952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Gur, M. S. Keshavan, and S. M. Lawrie
Deconstructing Psychosis With Human Brain Imaging
Schizophr Bull,
July 1, 2007;
33(4):
921 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gomez-Anson, M. Alegret, E. Munoz, A. Sainz, G. C. Monte, and E. Tolosa
Decreased frontal choline and neuropsychological performance in preclinical Huntington disease
Neurology,
March 20, 2007;
68(12):
906 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stadlbauer, C. Nimsky, S. Gruber, E. Moser, T. Hammen, T. Engelhorn, M. Buchfelder, and O. Ganslandt
Changes in Fiber Integrity, Diffusivity, and Metabolism of the Pyramidal Tract Adjacent to Gliomas: A Quantitative Diffusion Tensor Fiber Tracking and MR Spectroscopic Imaging Study
AJNR Am. J. Neuroradiol.,
March 1, 2007;
28(3):
462 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Kalra, A Vitale, N R Cashman, A Genge, and D L Arnold
Cerebral degeneration predicts survival in amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry,
November 1, 2006;
77(11):
1253 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lantz, M. Seeck, and F. Lazeyras
Extent of Preoperative Abnormalities and Focus Lateralization Predict Postoperative Normalization of Contralateral 1H-Magnetic Resonance Spectroscopy Metabolite Levels in Patients with Temporal Lobe Epilepsy.
AJNR Am. J. Neuroradiol.,
September 1, 2006;
27(8):
1766 - 1769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Wood, G. E. Berger, M. Lambert, P. Conus, D. Velakoulis, G. W. Stuart, P. Desmond, P. D. McGorry, and C. Pantelis
Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Arch Gen Psychiatry,
September 1, 2006;
63(9):
969 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.R. Amstutz, S.W. Coons, J.F. Kerrigan, H.L. Rekate, and J.E. Heiserman
Hypothalamic hamartomas: Correlation of MR imaging and spectroscopic findings with tumor glial content.
AJNR Am. J. Neuroradiol.,
April 1, 2006;
27(4):
794 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Reneman, M. M. L. de Win, W. van den Brink, J. Booij, and G. J. den Heeten
Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects
J Psychopharmacol,
March 1, 2006;
20(2):
164 - 175.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stadlbauer, S. Gruber, C. Nimsky, R. Fahlbusch, T. Hammen, R. Buslei, B. Tomandl, E. Moser, and O. Ganslandt
Preoperative Grading of Gliomas by Using Metabolite Quantification with High-Spatial-Resolution Proton MR Spectroscopic Imaging
Radiology,
March 1, 2006;
238(3):
958 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gallant, M. Rak, A. Szeghalmi, M. R. Del Bigio, D. Westaway, J. Yang, R. Julian, and K. M. Gough
Focally Elevated Creatine Detected in Amyloid Precursor Protein (APP) Transgenic Mice and Alzheimer Disease Brain Tissue
J. Biol. Chem.,
January 6, 2006;
281(1):
5 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Pears, J. D. Cooper, H. M. Mitchison, R. J. Mortishire-Smith, D. A. Pearce, and J. L. Griffin
High Resolution 1H NMR-based Metabolomics Indicates a Neurotransmitter Cycling Deficit in Cerebral Tissue from a Mouse Model of Batten Disease
J. Biol. Chem.,
December 30, 2005;
280(52):
42508 - 42514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Beacher, A. Simmons, E. Daly, V. Prasher, C. Adams, M. L. Margallo-Lana, R. Morris, S. Lovestone, K. Murphy, and D. G. M. Murphy
Hippocampal Myo-inositol and Cognitive Ability in Adults With Down Syndrome: An In Vivo Proton Magnetic Resonance Spectroscopy Study
Arch Gen Psychiatry,
December 1, 2005;
62(12):
1360 - 1365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Sassi, J. A. Stanley, D. Axelson, P. Brambilla, M. A. Nicoletti, M. S. Keshavan, R. T. Ramos, N. Ryan, B. Birmaher, and J. C. Soares
Reduced NAA Levels in the Dorsolateral Prefrontal Cortex of Young Bipolar Patients
Am J Psychiatry,
November 1, 2005;
162(11):
2109 - 2115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Caramanos, S. Narayanan, and D. L. Arnold
1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review
Brain,
November 1, 2005;
128(11):
2483 - 2506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Hanefeld, K. Brockmann, P.J.W. Pouwels, B. Wilken, J. Frahm, and P. Dechent
Quantitative proton MRS of Pelizaeus-Merzbacher disease: Evidence of dys- and hypomyelination
Neurology,
September 13, 2005;
65(5):
701 - 706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Md. A. Jalil, L. Begum, L. Contreras, B. Pardo, M. Iijima, M. X. Li, M. Ramos, P. Marmol, M. Horiuchi, K. Shimotsu, et al.
Reduced N-Acetylaspartate Levels in Mice Lacking Aralar, a Brain- and Muscle-type Mitochondrial Aspartate-glutamate Carrier
J. Biol. Chem.,
September 2, 2005;
280(35):
31333 - 31339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Staffen, H. Zauner, A. Mair, A. Kutzelnigg, P. Kapeller, H. Stangl, E. Raffer, H. Niederhofer, and G. Ladurner
Magnetic Resonance Spectroscopy of Memory and Frontal Brain Region in Early Multiple Sclerosis
J Neuropsychiatry Clin Neurosci,
August 1, 2005;
17(3):
357 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. KESHAVAN, G. BERGER, R. B. ZIPURSKY, S. J. WOOD, and C. PANTELIS
Neurobiology of early psychosis
The British Journal of Psychiatry,
August 1, 2005;
187(48):
s8 - s18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Williamson, P. R. Patrylo, J. Pan, D. D. Spencer, and H. Hetherington
Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy
Brain,
May 1, 2005;
128(5):
1199 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Lentz, J. P. Kim, S. V. Westmoreland, J. B. Greco, R. A. Fuller, E. M. Ratai, J. He, P. K. Sehgal, E. F. Halpern, A. A. Lackner, et al.
Quantitative Neuropathologic Correlates of Changes in Ratio of N-acetylaspartate to Creatine in Macaque Brain
Radiology,
May 1, 2005;
235(2):
461 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Wellard, R. S. Briellmann, C. Jennings, and G. D. Jackson
Physiologic Variability of Single-Voxel Proton MR Spectroscopic Measurements at 3T
AJNR Am. J. Neuroradiol.,
March 1, 2005;
26(3):
585 - 590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dubey, A. Fatemi, P. B. Barker, M. Degaonkar, M. Troeger, K. Zackowski, A. Bastian, S. A. Smith, M. G. Pomper, H. W. Moser, et al.
Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy
Neurology,
January 25, 2005;
64(2):
304 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. He, M. Inglese, B. S. Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen
Relapsing-Remitting Multiple Sclerosis: Metabolic Abnormality in Nonenhancing Lesions and Normal-appearing White Matter at MR Imaging: Initial Experience
Radiology,
January 1, 2005;
234(1):
211 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Astrakas, D. Zurakowski, A. A. Tzika, M. K. Zarifi, D. C. Anthony, U. De Girolami, N. J. Tarbell, and P. M. Black
Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors
Clin. Cancer Res.,
December 15, 2004;
10(24):
8220 - 8228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. M. Fernando, M. A. McLean, D. T. Chard, D. G. MacManus, C. M. Dalton, K. A. Miszkiel, R. M. Gordon, G. T. Plant, A. J. Thompson, and D. H. Miller
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis
Brain,
June 1, 2004;
127(6):
1361 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Freeman, L. T. Coleman, R. M. Wellard, M. J. Kean, J. V. Rosenfeld, G. D. Jackson, S. F. Berkovic, and A. S. Harvey
MR Imaging and Spectroscopic Study of Epileptogenic Hypothalamic Hamartomas: Analysis of 72 Cases
AJNR Am. J. Neuroradiol.,
March 1, 2004;
25(3):
450 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Vuori, L. Kankaanranta, A.-M. Hakkinen, E. Gaily, L. Valanne, M.-L. Granstrom, H. Joensuu, G. Blomstedt, A. Paetau, and N. Lundbom
Low-Grade Gliomas and Focal Cortical Developmental Malformations: Differentiation with Proton MR Spectroscopy
Radiology,
March 1, 2004;
230(3):
703 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Bianchi, M. Tosetti, R. Battini, M. L. Manca, M. Mancuso, G. Cioni, R. Canapicchi, and G. Siciliano
Proton MR Spectroscopy of Mitochondrial Diseases: Analysis of Brain Metabolic Abnormalities and Their Possible Diagnostic Relevance
AJNR Am. J. Neuroradiol.,
November 1, 2003;
24(10):
1958 - 1966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bernasconi, N. Bernasconi, J. Natsume, S. B. Antel, F. Andermann, and D. L. Arnold
Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy
Brain,
November 1, 2003;
126(11):
2447 - 2454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pizzini, Ali. S. Fatemi, P. B. Barker, L. M. Nagae-Poetscher, A. Horska, A. W. Zimmerman, H. W. Moser, G. Bibat, and S. Naidu
Proton MR Spectroscopic Imaging in Pelizaeus-Merzbacher Disease
AJNR Am. J. Neuroradiol.,
September 1, 2003;
24(8):
1683 - 1689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Zubler, M Seeck, T Landis, F Henry, and F Lazeyras
Contralateral medial temporal lobe damage in right but not left temporal lobe epilepsy: a 1H magnetic resonance spectroscopy study
J. Neurol. Neurosurg. Psychiatry,
September 1, 2003;
74(9):
1240 - 1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bonavita, A. Virta, N. Jeffries, E. Goldin, G. Tedeschi, and R. Schiffmann
Diffuse Neuroaxonal Involvement in Mucolipidosis IV as Assessed by Proton Magnetic Resonance Spectroscopic Imaging
J Child Neurol,
July 1, 2003;
18(7):
443 - 449.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt
Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy
Radiology,
July 1, 2003;
228(1):
185 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A.C. Petroff, L. D. Errante, J. H. Kim, and D. D. Spencer
N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus
Neurology,
May 27, 2003;
60(10):
1646 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Londono, M. Castillo, D. Armao, L. Kwock, and K. Suzuki
Unusual MR Spectroscopic Imaging Pattern of an Astrocytoma: Lack of Elevated Choline and High myo-Inositol and Glycine Levels
AJNR Am. J. Neuroradiol.,
May 1, 2003;
24(5):
942 - 945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Brockmann, P. Dechent, B. Wilken, O. Rusch, J. Frahm, and F. Hanefeld
Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease
Neurology,
March 11, 2003;
60(5):
819 - 825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bertolino, D. Sciota, F. Brudaglio, M. Altamura, G. Blasi, A. Bellomo, N. Antonucci, J. H. Callicott, T. E. Goldberg, T. Scarabino, et al.
Working Memory Deficits and Levels of N-Acetylaspartate in Patients With Schizophreniform Disorder
Am J Psychiatry,
March 1, 2003;
160(3):
483 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S.Y. Li, J. Regal, B. J. Soher, L. J. Mannon, R. I. Grossman, and O. Gonen
Brain Metabolite Profiles of T1-Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
January 1, 2003;
24(1):
68 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Rabinov, P. L. Lee, F. G. Barker, D. N. Louis, G. R. Harsh, G. R. Cosgrove, E. A. Chiocca, A. F. Thornton, J. S. Loeffler, J. W. Henson, et al.
In Vivo 3-T MR Spectroscopy in the Distinction of Recurrent Glioma versus Radiation Effects: Initial Experience
Radiology,
December 1, 2002;
225(3):
871 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. van der Knaap, S. Naidu, P. J.W. Pouwels, S. Bonavita, R. van Coster, L. Lagae, J. Sperner, R. Surtees, R. Schiffmann, and J. Valk
New Syndrome Characterized by Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum
AJNR Am. J. Neuroradiol.,
October 1, 2002;
23(9):
1466 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Dixon, K. M. Bradley, M. M. Budge, P. Styles, and A. D. Smith
Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease
Brain,
October 1, 2002;
125(10):
2332 - 2341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Eichler, R. Itoh, P. B. Barker, S. Mori, E. S. Garrett, P. C. M. van Zijl, H. W. Moser, G. V. Raymond, and E. R. Melhem
Proton MR Spectroscopic and Diffusion Tensor Brain MR Imaging in X-linked Adrenoleukodystrophy: Initial Experience
Radiology,
October 1, 2002;
225(1):
245 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Saindane, S. Cha, M. Law, X. Xue, E. A. Knopp, and D. Zagzag
Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR Am. J. Neuroradiol.,
September 1, 2002;
23(8):
1378 - 1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bertolino, J. L. Roffman, B. K. Lipska, P. van Gelderen, A. Olson, and D. R. Weinberger
Reduced N-Acetylaspartate in Prefrontal Cortex of Adult Rats with Neonatal Hippocampal Damage
Cereb Cortex,
September 1, 2002;
12(9):
983 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Summerfield, B. Gomez-Anson, E. Tolosa, J. M. Mercader, M. J. Marti, P. Pastor, and C. Junque
Dementia in Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study
Arch Neurol,
September 1, 2002;
59(9):
1415 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J W Pan, P K Coyle, K Bashir, J N Whitaker, L B Krupp, and H P Hetherington
Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy
Multiple Sclerosis,
June 1, 2002;
8(3):
200 - 206.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Eichler, P. Wang, R. J. Wityk, N. J. Beauchamp Jr, and P. B. Barker
Diffuse Metabolic Abnormalities in Reversible Posterior Leukoencephalopathy Syndrome
AJNR Am. J. Neuroradiol.,
May 1, 2002;
23(5):
833 - 837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Chu, G. F. Mason, J. W. Pan, H. P. Hetherington, H.-G. Liu, E. C. San Pedro, and J. M. Mountz
Regional Cerebral Blood Flow and Magnetic Resonance Spectroscopic Imaging Findings in Diaschisis From Stroke
Stroke,
May 1, 2002;
33(5):
1243 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Suhy, R.G. Miller, R. Rule, N. Schuff, J. Licht, V. Dronsky, D. Gelinas, A.A. Maudsley, and M.W. Weiner
Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI
Neurology,
March 12, 2002;
58(5):
773 - 779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bonneville, D. M. Moriarty, B. S.Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen
Whole-Brain N-Acetylaspartate Concentration: Correlation with T2-Weighted Lesion Volume and Expanded Disability Status Scale Score in Cases of Relapsing-Remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
March 1, 2002;
23(3):
371 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Reneman, C. B. L. M. Majoie, H. Flick, and G. J. den Heeten
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
AJNR Am. J. Neuroradiol.,
February 1, 2002;
23(2):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Takanashi, K. Inoue, M. Tomita, A. Kurihara, F. Morita, H. Ikehira, S. Tanada, E. Yoshitome, and Y. Kohno
Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication
Neurology,
January 22, 2002;
58(2):
237 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kuzniecky, C. Palmer, J. Hugg, R. Martin, S. Sawrie, R. Morawetz, E. Faught, and R. Knowlton
| |